SARS-CoV-2 Clinical Trials

A listing of SARS-CoV-2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 521 clinical trials
Featured trial
Pneumococcal Infection

prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), with a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal disease

covid-19
pneumococcal
polysaccharide
conjugate vaccine
  • 2 views
  • 13 Jan, 2022
  • 1 location
Featured trial
Pneumococcal Infection

prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), with a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal disease

covid-19
polysaccharide
  • 0 views
  • 18 Apr, 2022
  • 1 location
Featured trial
Global Healthy Living Foundation, The COvid19 Vaccine Response in Rheumatology patients (COVER) (Pro00054507)

Observational BOOSTER study to evaluate SARS-CoV-2 vaccines in a large population of patients with autoimmune conditions

  • 0 views
  • 30 Dec, 2022
  • 1 location
Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

If a treated cancer patient cannot make antibodies to a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Emergency Use Authorization (EUA) or approved vaccine, their risk for

  • 0 views
  • 07 Oct, 2022
  • 2 locations
National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) (ENFORCE)

National cohort study of effectiveness and safety of SARS-CoV-2 vaccines (ENFORCE is an equivalence trial to evaluate the effectiveness and safety of multiple new SARS-CoV-2 vaccines approved

Accepts healthy volunteers
  • 40 views
  • 26 Apr, 2022
  • 5 locations
A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

This is a phase 2, randomized, observer-blinded, placebo-controlled clinical study to evaluate the immunogenicity and safety of SARS-CoV-2 mRNA Vaccine (SYS6006)in healthy participants aged 18

Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location
An Open-Label, Phase 3 Study to Evaluate the Safety and Immunogenicity of the mRNA-1273.214 Vaccine for SARS-CoV-2 Variants of Concern in Participants Aged 6 Months to < 6 Years

This study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concerns (VOCs) in participants

Accepts healthy volunteers
  • 0 views
  • 24 Oct, 2022
  • 18 locations
Detection of COVID-19 Using Breath Analysis - Validation Study (COVID-19)

DETECTION OF THE 2019 NOVEL CORONAVIRUS (SARS-CoV-2) USING BREATH ANALYSIS- VALIDATION STUDY

Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location
COVID-19 Self-Testing Through Rapid Network Distribution (C-STRAND)

COVID-19, the coronavirus disease caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has led to a global pandemic and has exacerbated existing health inequities among

Accepts healthy volunteers
  • 0 views
  • 29 May, 2022
  • 1 location
A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 (TeenCove)

The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) infection. The study is designed to primarily

Accepts healthy volunteers
  • 0 views
  • 22 Apr, 2022
  • 1 location